Status: Not yet recruiting
Liquid Valine and Isoleucine in Maple Syrup Urine Disease
This is a prospective, observational research study in 5 children with Maple Syrup Urine Disease (MSUD). Subjects who are currently taking a valine and isoleucine supplement for MSUD will be recruited for a 56 day trial, of a new ready-to-use valine supplement and a new ready-to-use isoleucine supplement, to evaluate the tolerability and acceptability of the study products compared with their usual products.
Participants needed: 5
Trial details
Age: 12-16Biological sex: AllType: InterventionalSponsor: Meta Healthcare LtdUpdated: Sep 3, 2024
Eligibility criteria
Male and female MSUD patients ≥1 year and <16 years of age. [+5]
Age <1 year old and >16 years old. [+4]